Back to User profile » Dr Kristian Thorlund

Papers published by Dr Kristian Thorlund:


Logistical Challenges in Platform Randomized Trials - Operational Realities That Curb the Promise of Efficiency

Thorlund K, Park JJ, Wise MP, Doleman B, Petersen JJ, Lange T, Mathiesen O, Skrifvars MB, Saxena M, Nielsen N, Mills EJ, Grand J, Jakobsen JC

Clinical Epidemiology 2026, 18:580997

Published Date: 11 May 2026

Synthetic and External Controls in Clinical Trials – A Primer for Researchers

Thorlund K, Dron L, Park JJH, Mills EJ

Clinical Epidemiology 2020, 12:457-467

Published Date: 8 May 2020

Critical concepts in adaptive clinical trials

Park JJH, Thorlund K, Mills EJ

Clinical Epidemiology 2018, 10:343-351

Published Date: 23 March 2018

Nonergot dopamine-receptor agonists for treating Parkinson's disease – a network meta-analysis

Thorlund K, Wu P, Druyts E, Eapen S, Mills EJ

Neuropsychiatric Disease and Treatment 2014, 10:767-776

Published Date: 7 May 2014

Anti-tumor necrosis factor (TNF) drugs for the treatment of psoriatic arthritis: an indirect comparison meta-analysis

Thorlund K, Druyts E, Aviña-Zubieta JA, Mills EJ

Biologics: Targets and Therapy 2012, 6:417-427

Published Date: 3 December 2012

Budget impact analysis of boceprevir and telaprevir for the treatment of hepatitis C genotype 1 infection

Thorlund K, Druyts E, El Khoury AC, Mills EJ

ClinicoEconomics and Outcomes Research 2012, 4:349-359

Published Date: 16 November 2012

Boceprevir and telaprevir for the treatment of chronic hepatitis C genotype 1 infection: an indirect comparison meta-analysis

Cooper CL, Druyts E, Thorlund K, Nachega JB, El Khoury AC, O'Regan C, Mills EJ

Therapeutics and Clinical Risk Management 2012, 8:105-130

Published Date: 9 March 2012